Free Trial

MarketBeat Instant News Alerts

Trane Technologies logo with Construction background

Trane Technologies plc (NYSE:TT) Declares $0.94 Quarterly Dividend

Trane Technologies plc (NYSE:TT) announced a quarterly dividend on Wednesday, October 8th. Investors of record on Friday, December 5th will be given a dividend of 0.94 per share on Wednesday, December 31st. This represents a c) dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, December 5th.

NYSE:TT
Read Trane Technologies plc (NYSE:TT) Declares $0.94 Quarterly Dividend
Banco Bilbao Viscaya Argentaria logo with Finance background

Banco Bilbao Viscaya Argentaria S.A. Announces Dividend of $0.37 (NYSE:BBVA)

Banco Bilbao Viscaya Argentaria S.A. (NYSE:BBVA) announced a dividend on Tuesday, October 7th. Investors of record on Thursday, November 6th will be paid a dividend of 0.3736 per share by the bank on Monday, November 24th. This represents a yield of 395.0%. The ex-dividend date is Thursday, November 6th.

NYSE:BBVA
Read Banco Bilbao Viscaya Argentaria S.A. Announces Dividend of $0.37 (NYSE:BBVA)
Annexon logo with Medical background

Annexon's (ANNX) Sell (D-) Rating Reiterated at Weiss Ratings

Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Annexon in a research report on Wednesday.

NASDAQ:ANNX
Read Annexon's (ANNX) Sell (D-) Rating Reiterated at Weiss Ratings
Anika Therapeutics logo with Medical background

Weiss Ratings Reiterates "Sell (E+)" Rating for Anika Therapeutics (NASDAQ:ANIK)

Weiss Ratings reissued a "sell (e+)" rating on shares of Anika Therapeutics in a report on Wednesday.

NASDAQ:ANIK
Read Weiss Ratings Reiterates "Sell (E+)" Rating for Anika Therapeutics (NASDAQ:ANIK)
ANI Pharmaceuticals logo with Medical background

ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings

Weiss Ratings downgraded shares of ANI Pharmaceuticals from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday.

NASDAQ:ANIP
Read ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings
Anheuser-Busch InBev SA/NV logo with Consumer Staples background

Weiss Ratings Reiterates "Hold (C-)" Rating for Anheuser-Busch InBev SA/NV (NYSE:BUD)

Weiss Ratings reissued a "hold (c-)" rating on shares of Anheuser-Busch InBev SA/NV in a report on Wednesday.

NYSE:BUD
Read Weiss Ratings Reiterates "Hold (C-)" Rating for Anheuser-Busch InBev SA/NV (NYSE:BUD)

Trending News

All MarketBeat Instant News Alerts

AngloGold Ashanti logo with Basic Materials background

AngloGold Ashanti (NYSE:AU) Receives Hold (C+) Rating from Weiss Ratings

NYSE:AU
Read AngloGold Ashanti (NYSE:AU) Receives Hold (C+) Rating from Weiss Ratings
AngioDynamics logo with Medical background

Weiss Ratings Reiterates "Sell (D-)" Rating for AngioDynamics (NASDAQ:ANGO)

NASDAQ:ANGO
Read Weiss Ratings Reiterates "Sell (D-)" Rating for AngioDynamics (NASDAQ:ANGO)
Angi logo with Computer and Technology background

Angi (NASDAQ:ANGI) Cut to Sell (D+) at Weiss Ratings

NASDAQ:ANGI
Read Angi (NASDAQ:ANGI) Cut to Sell (D+) at Weiss Ratings
Anebulo Pharmaceuticals logo with Medical background

Weiss Ratings Reaffirms Sell (D-) Rating for Anebulo Pharmaceuticals (NASDAQ:ANEB)

NASDAQ:ANEB
Read Weiss Ratings Reaffirms Sell (D-) Rating for Anebulo Pharmaceuticals (NASDAQ:ANEB)
Andretti Acquisition Corp. II logo with Financial Services background

Andretti Acquisition Corp. II's (POLE) Sell (D-) Rating Reiterated at Weiss Ratings

NASDAQ:POLE
Read Andretti Acquisition Corp. II's (POLE) Sell (D-) Rating Reiterated at Weiss Ratings
Anavex Life Sciences logo with Medical background

Anavex Life Sciences (NASDAQ:AVXL) Given "Sell (D-)" Rating at Weiss Ratings

NASDAQ:AVXL
Read Anavex Life Sciences (NASDAQ:AVXL) Given "Sell (D-)" Rating at Weiss Ratings
AnaptysBio logo with Medical background

AnaptysBio's (ANAB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings

NASDAQ:ANAB
Read AnaptysBio's (ANAB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings
Analog Devices logo with Computer and Technology background

Analog Devices (NASDAQ:ADI) Receives "Buy (B-)" Rating from Weiss Ratings

NASDAQ:ADI
Read Analog Devices (NASDAQ:ADI) Receives "Buy (B-)" Rating from Weiss Ratings
Amylyx Pharmaceuticals logo with Medical background

Weiss Ratings Reaffirms Sell (E+) Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX)

NASDAQ:AMLX
Read Weiss Ratings Reaffirms Sell (E+) Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX)
Amtech Systems logo with Computer and Technology background

Amtech Systems' (ASYS) Sell (D-) Rating Reiterated at Weiss Ratings

NASDAQ:ASYS
Read Amtech Systems' (ASYS) Sell (D-) Rating Reiterated at Weiss Ratings
AMREP logo with Finance background

AMREP (NYSE:AXR) Earns "Hold (C+)" Rating from Weiss Ratings

NYSE:AXR
Read AMREP (NYSE:AXR) Earns "Hold (C+)" Rating from Weiss Ratings
Amplitude logo with Business Services background

Amplitude (NASDAQ:AMPL) Earns "Sell (E+)" Rating from Weiss Ratings

NASDAQ:AMPL
Read Amplitude (NASDAQ:AMPL) Earns "Sell (E+)" Rating from Weiss Ratings
AmpliTech Group logo with Computer and Technology background

Weiss Ratings Reaffirms "Sell (D-)" Rating for AmpliTech Group (NASDAQ:AMPG)

NASDAQ:AMPG
Read Weiss Ratings Reaffirms "Sell (D-)" Rating for AmpliTech Group (NASDAQ:AMPG)
Amphastar Pharmaceuticals logo with Medical background

Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings

NASDAQ:AMPH
Read Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings
Amneal Pharmaceuticals logo with Medical background

Amneal Pharmaceuticals (NASDAQ:AMRX) Receives Hold (C) Rating from Weiss Ratings

NASDAQ:AMRX
Read Amneal Pharmaceuticals (NASDAQ:AMRX) Receives Hold (C) Rating from Weiss Ratings
Amkor Technology logo with Computer and Technology background

Amkor Technology (NASDAQ:AMKR) Receives Hold (C) Rating from Weiss Ratings

NASDAQ:AMKR
Read Amkor Technology (NASDAQ:AMKR) Receives Hold (C) Rating from Weiss Ratings
Amicus Therapeutics logo with Medical background

Amicus Therapeutics (NASDAQ:FOLD) Given "Sell (E+)" Rating at Weiss Ratings

NASDAQ:FOLD
Read Amicus Therapeutics (NASDAQ:FOLD) Given "Sell (E+)" Rating at Weiss Ratings
Amgen logo with Medical background

Amgen (NASDAQ:AMGN) Stock Rating Upgraded by Weiss Ratings

NASDAQ:AMGN
Read Amgen (NASDAQ:AMGN) Stock Rating Upgraded by Weiss Ratings
AMERISAFE logo with Finance background

AMERISAFE's (AMSF) Hold (C) Rating Reaffirmed at Weiss Ratings

NASDAQ:AMSF
Read AMERISAFE's (AMSF) Hold (C) Rating Reaffirmed at Weiss Ratings
Americold Realty Trust logo with Finance background

Americold Realty Trust (NYSE:COLD) Earns "Sell (D+)" Rating from Weiss Ratings

NYSE:COLD
Read Americold Realty Trust (NYSE:COLD) Earns "Sell (D+)" Rating from Weiss Ratings
America's Car-Mart logo with Retail/Wholesale background

America's Car-Mart's (CRMT) "Sell (D)" Rating Reiterated at Weiss Ratings

NASDAQ:CRMT
Read America's Car-Mart's (CRMT) "Sell (D)" Rating Reiterated at Weiss Ratings
American Woodmark logo with Consumer Discretionary background

American Woodmark (NASDAQ:AMWD) Given "Hold (C)" Rating at Weiss Ratings

NASDAQ:AMWD
Read American Woodmark (NASDAQ:AMWD) Given "Hold (C)" Rating at Weiss Ratings
American Water Works logo with Utilities background

American Water Works (NYSE:AWK) Earns "Hold (C+)" Rating from Weiss Ratings

NYSE:AWK
Read American Water Works (NYSE:AWK) Earns "Hold (C+)" Rating from Weiss Ratings
American Vanguard logo with Basic Materials background

Weiss Ratings Reiterates "Sell (E+)" Rating for American Vanguard (NYSE:AVD)

NYSE:AVD
Read Weiss Ratings Reiterates "Sell (E+)" Rating for American Vanguard (NYSE:AVD)